Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment
ERLANGEN, GERMANY AND VILNIUS, LITHUANIA, Feb 4, 2025 – (ACN Newswire) – Mallia Therapeutics (“Mallia”), a biopharmaceutical company developing novel treatments for hair loss, and Northway Biotech (“NBT”), a biologics Contract Development and Manufacturing Organization (CDMO), have announced a partnership for the development of the production process and manufacturing of Mallia’s soluble CD83 protein (sCD83…
ERLANGEN, GERMANY AND VILNIUS, LITHUANIA, Feb 4, 2025 – (ACN Newswire) – Mallia Therapeutics (“Mallia”), a biopharmaceutical company developing novel treatments for hair loss, and Northway Biotech (“NBT”), a biologics Contract Development and Manufacturing Organization (CDMO), have announced a partnership for the development of the production process and manufacturing of Mallia’s soluble CD83 protein (sCD83…
Read More
About Author
